Home zacks
 

Keywords :   


Tag: zacks

Central Garden & Pet Co (CENT) Upgraded by Zacks Investment Research to Strong-Buy

2015-12-10 03:10:14| Chemicals - Topix.net

The firm currently has a $20.00 price objective on the stock. Zacks Investment Research 's target price suggests a potential upside of 17.79% from the stock's current price.

Tags: to research central garden

 

Zacks: J & J Snack Foods Corp (NASDAQ:JJSF) Given Average Rating of "Strong Buy" by Analysts

2015-12-09 20:01:52| Food - Topix.net

Shares of J & J Snack Foods Corp have received a consensus broker rating score of 1.00 from the one brokers that cover the company, Zacks Investment Research reports. One research analyst has rated the stock with a strong buy recommendation.

Tags: of buy rating average

 
 

Zacks: Pep Boys-Manny Moe and Jack (NYSE:PBY) Given $15.00 Consensus Target Price by Brokerages

2015-12-09 19:56:51| Auto Parts - Topix.net

Shares of Pep Boys-Manny Moe and Jack have been assigned a consensus broker rating score of 3.40 from the five analysts that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong sell recommendation, two have issued a hold recommendation and one has assigned a strong buy recommendation to the company.

Tags: price target jack consensus

 

OXiGENE Inc (OXGN) Stock Rating Lowered by Zacks Investment Research

2015-12-09 09:56:15| Biotech - Topix.net

According to Zacks, "OXiGENE, Inc. is an international biopharmaceutical company engaged principally in research into and the development of products for use in the treatment of cancer and other major diseases. " Separately, HC Wainwright lowered their target price on shares of OXiGENE from $6.00 to $4.00 and set a "buy" rating on the stock in a research note on Friday, October 2nd.

Tags: research rating stock investment

 

Sinovac Biotech Ltd. (SVA) Upgraded by Zacks Investment Research to "Hold"

2015-12-09 05:49:51| Biotech - Topix.net

According to Zacks, "Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, SARS, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.

Tags: to research hold investment

 

Sites : [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] next »